1. MHC class I loss is associated with biliary/progenitor cell features and “cold” tumor-immune microenvironment in hepatocellular carcinoma
   Yasuyuki Shigematsu et al, 2023, Virchows Archiv CrossRef
2. Tyrosine Kinase Inhibitors Stimulate HLA Class I Expression by Augmenting the IFNγ/STAT1 Signaling in Hepatocellular Carcinoma Cells
   Aya Takahashi et al, 2021, Frontiers in Oncology CrossRef